Skip to main content
. 2024 Feb 20;43(4):1335–1352. doi: 10.1007/s10067-024-06901-y

Table 1.

The clinical information in the three pSS-related datasets

GSE51092 GSE66795 GSE84844 Overall
(N = 222) (N = 160) (N = 60) (N = 442)
Group
  Control 32 (14.4%) 29 (18.1%) 30 (50.0%) 91 (20.6%)
  pSS 190 (85.6%) 131 (81.9%) 30 (50.0%) 351 (79.4%)
Age
  [20, 30] 0 (0%) 0 (0%) 7 (11.7%) 7 (1.6%)
  [30, 40] 0 (0%) 0 (0%) 10 (16.7%) 10 (2.3%)
  [40, 50] 0 (0%) 0 (0%) 15 (25.0%) 15 (3.4%)
  [50, 60] 0 (0%) 0 (0%) 10 (16.7%) 10 (2.3%)
  [60, 70] 0 (0%) 0 (0%) 12 (20.0%) 12 (2.7%)
  [70, 80] 0 (0%) 0 (0%) 6 (10.0%) 6 (1.4%)
Missing 222 (100%) 160 (100%) 0 (0%) 382 (86.4%)
Gender
  Female 0 (0%) 160 (100%) 59 (98.3%) 219 (49.5%)
  Male 0 (0%) 0 (0%) 1 (1.7%) 1 (0.2%)
  Missing 222 (100%) 0 (0%) 0 (0%) 222 (50.2%)